10/16/23 This material is for informational use only
So of course we give the usual recommendations that people should talk to their physician, et cetera, et cetera
HGH (Somatropin): FDA-approved for specific indications: pediatric growth hormone deficiency, adult GHD, Turner syndrome, HIV/AIDS-related wasting, short bowel syndrome Prescription-only medication requiring physician monitoring Illegal to distribute for off-label purposes including anti-aging (per the 1990 Anabolic Steroids Control Act amendments) Brand names include Genotropin, Norditropin, Humatrope, Saizen CJC-1295 and Ipamorelin: Neither is FDA-approved for any therapeutic indication Available as research compounds for laboratory use only (RUO Research Use Only) Not scheduled substances, but not approved for human therapeutic use Ipamorelin has undergone Phase I/II clinical trials (Johansen et al., 1999) but development did not progress to approval For a deeper look at Ipamorelin's regulatory history, see our Ipamorelin FDA approval status guide

One such promising medication is Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Assessing MCAS In many cases, MCAS is a clinical diagnosis
The upper GI tract was mainly enriched with Firmicutes, Proteobacteria and Lactobacillaceae , while the microbiota of lower GI tract was mainly composed of Bacteroidetes, Firmicutes, and A.muciniphila (Scheithauer et al., 2016